06:39:17 EDT Fri 14 May 2021
Enter Symbol
or Name

Login ID:

News for U:CLXPF from 2020-05-15 to 2021-05-14 - 21 items News ReleasesIn The NewsOther CAUS
2021-05-06 16:30U:CLXPFNews ReleaseCybin to Present at the Benzinga Global Small Cap Conference
2021-04-26 07:15U:CLXPFNews ReleaseCybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003
2021-04-21 07:15U:CLXPFNews ReleaseCybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the Treatment of Depression and Addiction
2021-04-19 09:04U:CLXPFNews ReleaseCybin to Present at the Bloom Burton & Co. Healthcare Investor Conference
2021-04-19 07:15U:CLXPFNews ReleaseCybin Establishes Clinical Advisory Board of Renowned Physicians, Dr. Maurizio Fava, Dr. Lynn Marie Morski and Dr. Anthony Back
2021-04-13 07:15U:CLXPFNews ReleaseCybin Advances IND-Enabling Studies of Two Psychedelic Molecules, CYB003 and CYB004 for Investigational New Drug Applications
2021-03-30 07:15U:CLXPFNews ReleaseCybin Announces Senior Management Changes to Lead Buildout of Development and Clinical Capabilities in the United States and Europe
2021-03-26 08:30U:CLXPFNews ReleaseCybin Inc. (NEO: CYBN) at Forefront of Psychedelic Revolution
2021-03-25 08:30U:CLXPFNews ReleaseCybin Inc. (NEO: CYBN) in Prime Position as Interest in Psychedelic Medicine Surges
2021-03-22 07:15U:CLXPFNews ReleaseCybin Signs Drug Development Agreement with Catalent for its Fast-Dissolve Formulation of Novel, Deuterated Tryptamine (CYB003)
2021-03-17 07:15U:CLXPFNews ReleaseCybin Progresses Two Psychedelic Investigational New Drug ( “IND ”) Candidates and Announces Completion of Its 20th Pre-Clinical Study
2021-03-16 07:15U:CLXPFNews ReleaseCybin to Present at the Oppenheimer 31st Annual Healthcare Conference
2021-03-15 07:15U:CLXPFNews ReleaseCybin to Present at the M Vest and Maxim Group 2021 Emerging Growth Virtual Conference
2021-03-10 09:15U:CLXPFNews ReleaseCybin to Present at the Stifel GMP Healthcare Conference – Healthcare Psychedelics: Addressing the Global Mental Health Crisis
2021-03-09 09:15U:CLXPFNews ReleaseCybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of Two Deuterated Candidates for Full IND Enabling Studies Based on Second Milestone Achievement Pursuant to the Adelia Acquisition
2021-03-08 06:00U:CLXPFNews ReleaseCybin Inc. Shares Commence Trading on the OTCQB Venture Market on March 8, 2021
2021-03-03 06:00U:CLXPFNews ReleaseCybin Inc. Announces Uplisting to OTCQB Venture Market
2021-01-11 12:19U:CLXPFNews ReleaseEmerging Markets Report: A Time to Grow
2020-10-19 11:30U:CLXPFNews ReleaseCybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO
2020-07-16 08:54U:CLXPFNews ReleaseClarmin Explorations Inc. Announces Proposed Management Team and Board of Directors of the Resulting Issuer
2020-06-29 14:54U:CLXPFNews ReleaseClarmin Explorations Inc. Enters Into Amalgamation Agreement for Reverse Takeover With Cybin Corp.